ElteN378

Target: ElteN378 is a high-affinity synthetic ligand for the FKBP12 protein target.

Mechanism of Action: ElteN378 can serve as a compact FKBP12-recognition ligand in degrader-format feasibility studies. Incorporated into a bifunctional PROTAC, the ElteN378-derived moiety binds FKBP12, while the linker and E3 ligase ligand recruit a ubiquitin ligase chosen for the cellular system. Degradation depends on more than ligand affinity: the linker must orient FKBP12 relative to the E3 complex so that a stable ternary complex forms. Productive recruitment enables ubiquitin transfer onto FKBP12, followed by recognition and turnover through the ubiquitin-proteasome pathway. This establishes a testable protein-depletion mechanism for research assays.

• PROTAC-Mediated Degradation Studies: ElteN378 can serve as a ligand component in PROTAC constructs to recruit an E3 ubiquitin ligase and drive ubiquitination of a chosen target protein. This enables systematic mapping of degradation potency, including concentration–response behavior, time dependence, and the relationship between ternary complex formation and target turnover.

• Target Selectivity Profiling: By pairing ElteN378 with different target-binding modules, researchers can evaluate how ligand geometry and binding kinetics influence selective degradation across related proteins. This supports comparative studies of off-target ubiquitination, degradation specificity, and pathway dependence, using immunoblotting, proteomics, and ubiquitin engagement assays.

• Ternary Complex Optimization: ElteN378-based PROTACs can be engineered to enhance cooperative binding between the target protein, the E3 ligase, and the chimeric molecule. Researchers can use biophysical and cellular readouts to optimize linker length, attachment points, and conformational constraints to improve ternary complex stability and thereby increase degradation efficiency.

• Mechanistic Pathway Dissection: ElteN378 can be utilized to probe the mechanistic basis of targeted protein degradation by varying PROTAC design parameters and assessing ubiquitin–proteasome involvement. Experiments can include proteasome inhibition sensitivity, lysosomal contribution testing, and evaluation of ubiquitin chain types to clarify degradation routes and kinetics.

ElteN378 is a chiral piperidine carboxamide scaffold with aromatic and carbonyl-rich structural features that may support exploratory ligand design.

Structure: ElteN378 is a chiral piperidine-2-carboxamide bearing a phenylpropyl amide substituent and a phenylglyoxyl-type N-acyl group. The molecule contains two amide/carbonyl regions, aromatic hydrophobic groups, and one stereochemically defined piperidine center.

Reactivity: The amide and α-dicarbonyl/benzoyl regions may contribute to recognition and should not be modified without SAR support. If a target-binding role is confirmed, linker installation would likely require analog synthesis from the phenylpropyl or piperidine periphery. Alkyl, PEG, amide, or carbamate linkers may then be connected to CRBN, VHL, or IAP ligands.